1. Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
   Anne Fougerat et al, 2020, Cells CrossRef
2. Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway.
   Carl G Gottschalk et al, 2021, J Neurosci CrossRef
3. Metformin mitigates renal dysfunction in obese insulin-resistant rats via activation of the AMPK/PPARα pathway
   Laongdao Thongnak et al, 2023, Arch. Pharm. Res. CrossRef
4. Therapeutic targets for metabolic dysfunction-associated steatotic liver disease and their roles in hepatocellular carcinoma
   Chenyu Wei et al, 2023, Explor Dig Dis CrossRef